Ontology highlight
ABSTRACT: Background
Immune-mediated demyelination and consequent degeneration of oligodendrocytes and axons are hallmark features of multiple sclerosis (MS). Remyelination declines in progressive MS, causing permanent axonal loss and irreversible disabilities. Strategies aimed at enhancing remyelination are critical to attenuate disease progression.Objective
We systematically reviewed recent advances in neuroprotective and regenerative therapies for MS, covering preclinical and clinical studies.Methods
We searched three biomedical databases using defined keywords. Two authors independently reviewed articles for inclusion based on pre-specified criteria. The data were extracted from each study and assessed for risk of bias.Results
Our search identified 7351 studies fr
SUBMITTER: Allanach JR
PROVIDER: S-EPMC8688986 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature